Company: CERO
Filing Date: 2025-02-07
Form Type: 424B3
Source: 0001213900-25-011071
Chunk: 296

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-02-07
Form: 424B3
Chunk 296
---
, such Private Placement Warrants will be subject to a lock-up in compliance
with FINRA Rule 5110(e) and may not be exercised after five years from the commencement of sales of our Initial Public Offering in accordance
with FINRA Rule 5110(g)(8)(A). The Private Placement Warrants will be redeemable by us and exercisable by the holders on the same basis
as the Public Warrants.

Conversion Warrants

Exercise Price. The
Conversion Warrants are initially exercisable for cash at an exercise price equal to $10.00. The exercise price is subject to adjustment
for stock splits, combinations and similar events, and, in the event of stock dividends and splits, the number of shares of Common Stock
issuable upon the exercise of the Conversion Warrant will also be adjusted so that the aggregate exercise price shall be the same immediately
before and immediately after any such adjustment.

Exercise Period.
The Conversion Warrants will expire five years after their issuance, or November 14, 2024.

Automatic Conversion.
The Conversion Warrants will automatically convert at the end of the exercise period if the fair market value (as determined in the Conversion
Warrants) of a share of Common Stock underlying the Conversion Warrants is greater than the exercise price in effect on such date.

<div align='center'>173</div>

Common Warrants

Series A Warrants

Exercise Price. The
Series A Warrants were initially exercisable for cash at an exercise price equal to the greater of (x) $920.00 (as adjusted for stock
splits, stock dividends, stock combinations, recapitalizations and similar events) and (y) the closing price of the Common Stock on the
trading day immediately prior to the Subscription Date (as defined in the Series A Warrant). As of the date of this prospectus, the current
exercise price of the Series A Warrants is $139.00. The exercise price is subject to adjustment for stock splits, combinations and similar
events, and, in the event of stock dividends and splits, the number of shares of Common Stock issuable upon the exercise of the Series
A Warrant will also be adjusted so that the aggregate exercise price shall be the same immediately before and immediately after any such
adjustment.

April Exercise Price Adjustment. The Series A Warrants were subject to an adjustment whereby, if the exercise price in effect as of the First Stockholder
Approval Date was greater than the lesser of (i) the closing price of